31 – 40 of 48
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Structural and Functional Analysis of the ApolipoproteinA-I A164S Variant.
(
- Contribution to journal › Article
- 2014
-
Mark
Single injections of apoA-I acutely improve in vivo glucose tolerance in insulin-resistant mice.
(
- Contribution to journal › Article
-
Mark
Superantigen activates the gp130 receptor on adipocytes resulting in altered adipocyte metabolism.
(
- Contribution to journal › Article
-
Mark
Galiellalactone is a Direct Inhibitor of STAT3 in Prostate Cancer Cells.
(
- Contribution to journal › Article
-
Mark
The fungal metabolite galiellalactone interferes with the nuclear import of NF-κB and inhibits HIV-1 replication.
(
- Contribution to journal › Article
-
Mark
Secondary Structure Changes in ApoA-I Milano (R173C) Are Not Accompanied by a Decrease in Protein Stability or Solubility.
(
- Contribution to journal › Article
-
Mark
Conformational and aggregation properties of the 1-93 fragment of apolipoprotein A-I
(
- Contribution to journal › Article
-
Mark
APOLIPOPROTEIN A-I DERIVED PEPTIDES FOR TREATMENT OF HYPERGLYCAEMIA
2014) 019-094-625-110-905(
- Patent › Patent
- 2013
-
Mark
Discoidal HDL and apoA-I-derived peptides improve glucose uptake in skeletal muscle.
(
- Contribution to journal › Article
-
Mark
Double Electron-Electron Resonance Probes Ca2+-Induced Conformational Changes and Dimerization of Recoverin
(
- Contribution to journal › Article